Modjarrad K. (2016). MERS-CoV vaccine candidates in development: The current landscape. Vaccine, 34(26), 2982–2987. https://doi.org/10.1016/j.vaccine.2016.03.104

Bosaeed, M., Balkhy, H. H., Almaziad, S., Aljami, H. A., Alhatmi, H., Alanazi, H., Alahmadi, M., Jawhary, A., Alenazi, M. W., Almasoud, A., Alanazi, R., Bittaye, M., Aboagye, J., Albaalharith, N., Batawi, S., Folegatti, P., Ramos Lopez, F., Ewer, K., Almoaikel, K., Aljeraisy, M., … Khalaf Alharbi, N. (2022). Safety and immunogenicity of ChAdOx1 MERS vaccine candidate in healthy Middle Eastern adults (MERS002): an open-label, non-randomised, dose-escalation, phase 1b trial. The Lancet. Microbe, 3(1), e11–e20. https://doi.org/10.1016/S2666-5247(21)00193-2

Folegatti, P. M., Bittaye, M., Flaxman, A., Lopez, F. R., Bellamy, D., Kupke, A., Mair, C., Makinson, R., Sheridan, J., Rohde, C., Halwe, S., Jeong, Y., Park, Y. S., Kim, J. O., Song, M., Boyd, A., Tran, N., Silman, D., Poulton, I., Datoo, M., … Gilbert, S. (2020). Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial. The Lancet. Infectious diseases, 20(7), 816–826. https://doi.org/10.1016/S1473-3099(20)30160-2

Modjarrad, K., Roberts, C. C., Mills, K. T., Castellano, A. R., Paolino, K., Muthumani, K., Reuschel, E. L., Robb, M. L., Racine, T., Oh, M. D., Lamarre, C., Zaidi, F. I., Boyer, J., Kudchodkar, S. B., Jeong, M., Darden, J. M., Park, Y. K., Scott, P. T., Remigio, C., Parikh, A. P., … Maslow, J. N. (2019). Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial. The Lancet. Infectious diseases, 19(9), 1013–1022. https://doi.org/10.1016/S1473-3099(19)30266-X

Graham, R. L., Donaldson, E. F., & Baric, R. S. (2013). A decade after SARS: strategies for controlling emerging coronaviruses. Nature reviews. Microbiology, 11(12), 836–848. https://doi.org/10.1038/nrmicro3143

Chafekar, A., & Fielding, B. C. (2018). MERS-CoV: Understanding the Latest Human Coronavirus Threat. Viruses, 10(2), 93. https://doi.org/10.3390/v10020093